This session will focus on roles and obligations of various stakeholders in conducting clinical research, including brief discussions of expanded access programs and investigator-initiated research.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 5: Sponsor, Investigator, and Institutional Review Board Responsibilities

Session Chair(s)

JP Clement, MD

Be informed and stay engaged.